Liu Feng-Jun, Liu Li, He Fang, Wang Su, Zhou Tao-You, Liu Cong, Deng Lin-Yu, Tang Hong
Center of Infectious Diseases, Division of Molecular Biology of infectious Diseases, National Key Laboratory of Biotherapy (Sichuan University), West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China.
World J Gastroenterol. 2007 Oct 28;13(40):5324-30. doi: 10.3748/wjg.v13.i40.5324.
To establish a rapid and convenient animal model with hepatitis B virus (HBV) replication.
A naked DNA solution of HBV-replication-competent plasmid was transferred to BALB/C mice via the tail vein, using a hydrodynamic in vivo transfection procedure. After injection, these mice were sacrificed on d 1, 3, 4, 5, 7 and 10. HBV DNA replication intermediates in the liver were analyzed by Southern blot hybridization. The expression of hepatitis B core antigen (HBcAg) and hepatitis B surface antigen (HBsAg) in the liver was checked by immunohistochemistry. Serum HBsAg and hepatitis B e antigen (HBeAg) was detected by enzyme-linked immunosorbent assay (ELISA). Inhibition of HBV replication was compared in HBV replication model mice treated intraperitoneally with polyinosinic-polytidylin acid (polyIC) or phosphate-buffered saline (PBS).
After hydrodynamic in vivo transfection, HBV DNA replication intermediates in the mouse liver were detectable on d 1 and abundant on d 3 and 4, the levels were slightly decreased and remained relatively stable between d 5 and 7, and were almost undetectable on d 10. The expression patterns of HBcAg and HBsAg were similar to that of HBV replication intermediate DNA, except that they reached a peak on d 1 after injection. No obvious differences in HBV DNA replication intermediates were observed in the left, right and middle lobes of the liver. After treatment with polyIC, the level of HBV intermediate DNA in the liver was lower than that in the control mice injected with PBS.
A rapid and convenient mouse model with a high level of HBV replication was developed and used to investigate the inhibitory effect of polyIC on HBV replication, which provides a useful tool for future functional studies of the HBV genome.
建立一种快速便捷的乙型肝炎病毒(HBV)复制动物模型。
采用体内流体动力学转染方法,将具有HBV复制能力的质粒裸DNA溶液经尾静脉注射到BALB/C小鼠体内。注射后,于第1、3、4、5、7和10天处死这些小鼠。通过Southern印迹杂交分析肝脏中的HBV DNA复制中间体。采用免疫组织化学法检测肝脏中乙型肝炎核心抗原(HBcAg)和乙型肝炎表面抗原(HBsAg)的表达。通过酶联免疫吸附测定(ELISA)检测血清中的HBsAg和乙型肝炎e抗原(HBeAg)。比较腹腔注射聚肌苷酸-聚胞苷酸(polyIC)或磷酸盐缓冲盐水(PBS)的HBV复制模型小鼠对HBV复制的抑制作用。
经体内流体动力学转染后,小鼠肝脏中的HBV DNA复制中间体在第1天可检测到,第3天和第4天大量存在,其水平在第5天至第7天略有下降并保持相对稳定,在第10天几乎检测不到。HBcAg和HBsAg的表达模式与HBV复制中间体DNA相似,只是在注射后第1天达到峰值。在肝脏的左叶、右叶和中叶未观察到HBV DNA复制中间体有明显差异。用polyIC处理后,肝脏中HBV中间体DNA的水平低于注射PBS的对照小鼠。
建立了一种快速便捷、HBV复制水平高的小鼠模型,并用于研究polyIC对HBV复制的抑制作用,为今后HBV基因组的功能研究提供了有用的工具。